By Dean Andromidas,
The Schiller Institute
March 8, 2013 EIR Economics 27
Sanofi, have stopped shipments of drugs to Greece because of nonpayment. The country’s social
insurance funds and hospitals owe pharmaceutical companies EU1.9 billion, going back to 2011. In turn,
the government owes Greek hospitals and the insurance fund EU3 billion. The shortages include medications
for arthritis, hepatitis C, and hypertension, cholesterol-lowering agents, anti-psychotics, antibiotics,
anesthetics, and immunomodulators used to treat bowel disease.